2005
DOI: 10.1016/j.jaci.2004.11.010
|View full text |Cite
|
Sign up to set email alerts
|

Glucocorticoid-induced surface expression of annexin 1 blocks β2-integrin adhesion of human eosinophils to intercellular adhesion molecule 1 surrogate protein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
25
1

Year Published

2006
2006
2016
2016

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(26 citation statements)
references
References 23 publications
0
25
1
Order By: Relevance
“…AnxA1 was first identified as a factor that was released from GC-stimulated cells in vitro or in vivo, and exerted anti-inflammatory effects mirroring those of GCs. Most notably it inhibited release of proinflammatory prostaglandins, and impaired leukocyte extravasation at sites of inflammation (Chatterjee et al, 2005;de Coupade et al, 2003;Gavins et al, 2003;Lim and Pervaiz, 2007;Liu et al, 2005;Parente and Solito, 2004). AnxA1 is relocalized from the cytoplasm to the plasma membrane in response to a variety of agonists including GCs, and can be externalized or secreted via an uncharacterized mechanism.…”
Section: Annexin A1mentioning
confidence: 99%
“…AnxA1 was first identified as a factor that was released from GC-stimulated cells in vitro or in vivo, and exerted anti-inflammatory effects mirroring those of GCs. Most notably it inhibited release of proinflammatory prostaglandins, and impaired leukocyte extravasation at sites of inflammation (Chatterjee et al, 2005;de Coupade et al, 2003;Gavins et al, 2003;Lim and Pervaiz, 2007;Liu et al, 2005;Parente and Solito, 2004). AnxA1 is relocalized from the cytoplasm to the plasma membrane in response to a variety of agonists including GCs, and can be externalized or secreted via an uncharacterized mechanism.…”
Section: Annexin A1mentioning
confidence: 99%
“…Prior in vivo and in vitro studies have demonstrated that blockade of gIVaPLA 2 inhibits 1) cellular adhesion/migration of eosinophils and lymphocytes (12)(13)(14), 2) synthesis of arachidonate metabolites (15)(16)(17)(18)(19)(20), and 3) airway narrowing (21)(22)(23). Mammalian secretory 14-kDa PLA 2 s, e, g., gVPLA 2, gIIaPLA 2 , and gXPLA 2 , are inflammatory enzymes that are involved directly and indirectly in inducing inflammatory and allergic processes; however, the mode of action of these sPLA 2 isoforms has not been fully established.…”
mentioning
confidence: 99%
“…Other studies have demonstrated substantially greater AHR in immunosensitized gIVaPLA 2 wild-type (WT) mice than in gIVaPLA 2 knockout mice (23,34,37). Although much attention has been focused on gIVaPLA 2 as the critical regulating enzyme in integrin adhesion (12)(13)(14) and eicosanoid generation (15)(16)(17)(18)(19)(20), the signal initiating stimulus that triggers the activation of inflammatory cells to cause cell migration and AHR in chronic asthma has not been defined. We have demonstrated that gVPLA 2 can trigger the biosynthesis and release of LTB 4 from human neutrophils (32,33) in a gIVaPLA 2 -dependent manner and LTC 4 from human eosinophils in a gIVaPLA 2 -independent manner (34,35).…”
mentioning
confidence: 99%
“…ALDH1A1 can perturb murine hematopoiesis by promoting myeloid differentiation at the expense of lymphopoiesis [29]. Glucocorticoid-induced surface expression of ANXA1 blocks beta 2-integrin adhesion of human eosinophils to intercellular adhesion molecule 1 surrogate protein [15]. IL33 potently induces effector functions and cytokine production, enhances adhesion, and prolongs survival of eosinophils [4,5,26,36].…”
Section: Discussionmentioning
confidence: 99%